Fouad Namouni Aprea Therapeutics, Inc. (APRE) insider trading activity

APRE Quotes by TradingView

Fouad Namouni is Director of Aprea Therapeutics, Inc.. Currently has a direct ownership of 4,610 shares of APRE, which is worth approximately $18,901. The most recent transaction as insider was on Jun 30, 2021, when has been sold 4,610 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.61K
0% 3M change
0% 12M change
Total Value Held $18,901

Fouad Namouni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2021
BUY
Grant, award, or other acquisition
-
4,610 Added 50.0%
4,610 Common Stock

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
PRESIDENT, R & D
VOR
Vor Biopharma Inc. Healthcare
FN

Fouad Namouni

Director
Cambridge, MA

Track Institutional and Insider Activities on APRE

Follow Aprea Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells APRE shares.

Notify only if

Insider Trading

Get notified when an Aprea Therapeutics, Inc. insider buys or sells APRE shares.

Notify only if

News

Receive news related to Aprea Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on APRE